Virbac and SymbioCellTech Sign Exclusive Option Agreement to Develop Novel Technology for Treatment of Type 1 Diabetes in Companion Animals
SALT LAKE CITY, UT and CARROS, FRANCE / ACCESSWIRE / January 12, 2021 / SymbioCellTech, LLC (SCT), a biotechnology company...